[Form 4] Weyco Group Inc Insider Trading Activity
Katherine Destinon, Vice President and President - Nunn Bush at Weyco Group Inc (WEYS), reported an equity award vesting and her current holdings. The filing shows a non‑derivative acquisition on 08/25/2025 of 1,695 shares at a reported price of $0, bringing her total beneficial ownership to 8,080 shares. The report also lists four outstanding stock option grants exercisable through 2033 that underlie a total of 8,363 shares: 500 (exercise $18), 2,401 ($24), 2,341 ($28.83) and 3,121 ($25.79). Vesting schedules for each option grant are noted as 20% per year for five years beginning on the grant dates in 2021–2024.
- Increased direct ownership: acquisition of 1,695 shares on 08/25/2025 raising beneficial ownership to 8,080 shares
- Transparent option disclosures: four option grants detailed with exercise prices, quantities, expiration dates, and vesting schedules
- Potential dilution: outstanding options underlie 8,363 shares which could dilute existing shareholders if exercised
Insights
TL;DR: Insider acquired 1,695 shares through an award; total direct holdings are modest and options add potential share upside.
The 08/25/2025 non‑derivative entry records an acquisition of 1,695 shares at a reported price of $0, increasing Katherine Destinon's beneficial ownership to 8,080 shares. For investors, the transaction appears to reflect vesting or a grant rather than an open‑market purchase, given the $0 price. The listed stock options total 8,363 underlying shares with exercise prices ranging from $18 to $28.83 and expirations through 2033, subject to 20% annual vesting schedules. Overall, the disclosure indicates continued ownership and option exposure but does not alone signal a material shift in capital structure.
TL;DR: Report documents routine management vesting and option schedules; governance implications are standard and non‑material.
The Form 4 identifies Destinon as an officer (VP, President - Nunn Bush) and shows an in‑period acquisition of 1,695 shares at $0, consistent with award vesting or plan issuance. The presence of multiple option grants with explicit 20% per year vesting is disclosed transparently, including exercise prices and expiration dates. From a governance perspective, disclosures are complete and timely; there is no indication of unusual related‑party transactions or exceptions in the filing text.